All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of natural killer cell proliferation | GO_0032819 |
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
| positive regulation of natural killer cell activation | GO_0032816 |
Any process that activates or increases the frequency, rate or extent of natural killer cell activation.
|
| sterol response element binding | GO_0032810 |
Binding to a sterol response element (SRE), a nonpalindromic sequence found in the promoters of genes involved in lipid metabolism.
|
| positive regulation of epinephrine secretion | GO_0032812 |
Any process that activates or increases the frequency, rate or extent of the regulated release of epinephrine.
|
| negative regulation of epinephrine secretion | GO_0032811 |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.
|
| DNA ligase IV complex | GO_0032807 |
A eukaryotically conserved protein complex that contains DNA ligase IV and is involved in DNA repair by non-homologous end joining; in addition to the ligase, the complex also contains XRCC4 or a homolog, e.g. Saccharomyces Lif1p.
|
| neuronal cell body membrane | GO_0032809 |
The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites.
|
| lacrimal gland development | GO_0032808 |
The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.
|
| obsolete receptor biosynthetic process | GO_0032800 |
OBSOLETE. The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
| regulation of low-density lipoprotein particle receptor catabolic process | GO_0032803 |
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.
|
| low-density lipoprotein particle receptor catabolic process | GO_0032802 |
The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
| low-density lipoprotein receptor particle metabolic process | GO_0032799 |
The chemical reactions and pathways involving low-density lipoprotein receptors.
|
| positive regulation of low-density lipoprotein particle receptor catabolic process | GO_0032805 |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.
|
| negative regulation of low-density lipoprotein particle receptor catabolic process | GO_0032804 |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein receptors.
|
| negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | GO_0032830 |
Any process that stops, prevents, or reduces the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|
| regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | GO_0032829 |
Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|
| dendrite cytoplasm | GO_0032839 |
All of the contents of a dendrite, excluding the surrounding plasma membrane.
|
| neuron projection cytoplasm | GO_0120111 |
All of the contents of a plasma membrane bounded neuron projection, excluding the plasma membrane surrounding the projection.
|
| regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response | GO_0032832 |
Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells as part of an immune response.
|
| positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | GO_0032831 |
Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|